86
Participants
Start Date
June 30, 2010
Primary Completion Date
June 30, 2013
Study Completion Date
September 30, 2013
Paclitaxel / Carboplatin
Patients will receive commercially available paclitaxel (200 mg/m2) and carboplatin (target area under the concentration-time curve \[AUC\] 6) on Day 1 of each 21 day cycle for up to 6 cycles.
bavituximab
Patients will receive 3 mg/kg bavituximab, administered weekly until progression or toxicity.
Gettysburg Cancer Center, Gettysburg
Delta Hematology Oncology Associates, PC, Portsmouth
Presbyterian Hospital, Charlotte
Baptist Cancer Institute, Jacksonville
Hematology-Oncology of Knoxville/Mercy Medical Center, Knoxville
Gabrail Cancer Center, Canton
Signal Point Clinical Research Center, LLC, Middletown
The Christ Hospital Cancer Center Research, Cincinnati
Community Hospital, Munster
City multi-field clinical hospital # 4, Department of chemotherapy; Dnipropetrovsk State Medical Academy, Chair of Oncology and Medical Radiology;, Dnipropetrovsk
Cedar Valley Medical Specialists, PC, Waterloo
"State Institution Institute of Medical Radiology named after S.P. Grygoryev of AMS of Ukraine, department of chemotherapy", Kharkiv
Southeast Nebraska Cancer Center, Lincoln
Baptist Clinical Research, Jonesboro
"Municipal Clinical Medical and Prophylactic Institution Donetsk Regional Antineoplastic Center, onco-chemotherapy department #1", Donetsk
Ironwood Cancer and Research Center, Chandler
San Juan Oncology Associates, Farmington
Uzhgorod Central City Clinical Hospital, City Oncology Center, Uzhhorod
American Institute of Research, Whittier
"Institution of Russian Academy of Medical Science Russian Oncology Scientific Centre named after N. N. Blokhina RAMN", Moscow
O.P. Jindal Institute of Cancer & Research, Hisar
"State Institution of Healthcare of Yaroslavl Region Regional Clinical Oncology Hospital", Yaroslavl
"State Institution of Healthcare Ivanovo Regional Oncology Dispensary ", Ivanovo
"State Educational Institution of Higher Professional Education Saint-Petersburg State Medical University named after academician I.P. Pavlov of Federal Agency of Healthcare and Social Development", Saint Petersburg
"State Institution of Healthcare Tula Regional Oncology Dispensary", Tula
SMS Medical College Hospital, Jaipur
"State Institution of Healthcare Pyatigorsk Oncology Dispensary", Pyatigorsk
Cancer Care Clinic, Nagpur
"State Medical Preventive Institution Chelyabinsk Regional Clinical Oncology", Chelyabinsk
BiBi General Hospital & Cancer Centre, Hyderabad
Bangalore Institute of Oncology Specialty Centre, Bangalore
Mahavir Cancer Sansthan, Patna
Dartmouth Hitchcock Medical Center, Lebanon
The Center for Cancer and Hematologic Disease, Cherry Hill
JSC A.Gvamichava National Oncology Center, Tbilisi
Medulla Chemotherapy and Immunotherapy Clinic, Tbilisi
Kodlikeri Memorial Hospital, Aurangabad
Shatabdi Superspecialty Hospital, Nashik
Ruby Hall Clinic, Pune
Kyiv City Oncology Hospital, Thoracal Department, Kyiv
Lead Sponsor
Peregrine Pharmaceuticals
INDUSTRY